A B S T R A C T Isolated rat thymocytes were preincubated with various catecholamines, alone and together with 3,5,3'-triiodothyronine (T3), and the accumulation of the glucose analogues, 2-deoxy-D-glucose (2-DG) and 3-0-methylglucose (3-0-MG), was then measured. Epinephrine induced a time-and dose-dependent increase in the 15-min accumulation of 2-DG; at a concentration of 100 ,uM epinephrine, the effect was evident after a preincubation period of only 5 min. The lowest concentration of epinephrine at which a significant effect was evident was 1 uM. Epinephrine also produced a dose-dependent increase in the accumulation of 3-0-MG, and the lowest concentration at which a significant effect was evident was again 1 uM. Isoproterenol, a f-adrenergic agonist, like epinephrine, increased the accumulation of 2-DG, whereas the aagonist, phenylephrine, had no effect. The response to epinephrine was inhibited by the ,8-antagonist, alprenolol, but the a-antagonist, phentolamine, had no effect. As previously demonstrated, T3 increased 2-DG accumulation, and like epinephrine, its effect was blocked by alprenolol. Neither T3 (0.1 nM) nor epinephrine (0.1 uM) had any effect when acting alone, but when added together at these concentrations, they significantly increased the accumulation of both 2-DG and 3-0-MG. Neither T3 with isoproterenol nor T3 with phenylephrine produced a comparable synergistic effect. But T3 (0.1 nM) acting with isoproterenol (0.1 ,M) and phenylephrine (0.1 ,\M) together, synergistically increased 2-DG accumulation. In addition, the a-antagonist, phentolamine, which alone had no effect, inhibited the synergistic effect induced by T3 and epinephrine. The effects of epinephrine and T3 alone, as well as their combined synergistic effect on 2-DG accumulation, were not blocked by the inhibitor of protein synthesis, puromycin.
A B S T R A C T Isolated rat thymocytes were preincubated with various catecholamines, alone and together with 3,5,3'-triiodothyronine (T3), and the accumulation of the glucose analogues, 2-deoxy-D-glucose (2-DG) and 3-0-methylglucose (3-0-MG), was then measured. Epinephrine induced a time-and dose-dependent increase in the 15-min accumulation of 2-DG; at a concentration of 100 ,uM epinephrine, the effect was evident after a preincubation period of only 5 min. The lowest concentration of epinephrine at which a significant effect was evident was 1 uM. Epinephrine also produced a dose-dependent increase in the accumulation of 3-0-MG, and the lowest concentration at which a significant effect was evident was again 1 uM. Isoproterenol, a f-adrenergic agonist, like epinephrine, increased the accumulation of 2-DG, whereas the aagonist, phenylephrine, had no effect. The response to epinephrine was inhibited by the ,8-antagonist, alprenolol, but the a-antagonist, phentolamine, had no effect. As previously demonstrated, T3 increased 2-DG accumulation, and like epinephrine, its effect was blocked by alprenolol. Neither T3 (0.1 nM) nor epinephrine (0.1 uM) had any effect when acting alone, but when added together at these concentrations, they significantly increased the accumulation of both 2-DG and 3-0-MG. Neither T3 with isoproterenol nor T3 with phenylephrine produced a comparable synergistic effect. But T3 (0.1 nM) acting with isoproterenol (0.1 ,M) and phenylephrine (0.1 ,\M) together, synergistically increased 2-DG accumulation. In addition, the a-antagonist, phentolamine, which alone had no effect, inhibited the synergistic effect induced by T3 and epinephrine. The effects of epinephrine and T3 alone, as well as their combined synergistic effect on 2-DG accumulation, were not blocked by the inhibitor of protein synthesis, puromycin.
INTRODUCTION
The primary mechanism of action of the thyroid hormnones remains uncertain, despite extensive interest in this question. In previous studies we have presented evidence suggesting that, in addition to the actions on the nucleus and mitochondrion postulated by others (1) (2) (3) (4) (5) , a primary action of the hormones is also exerted at the level of the plasma membrane. Part of this evidence is the finding that in the isolated rat thymocyte in vitro, 3,5,3'-triiodothyronine (T3)' promptly stimulates both the accumulation of certain amino acids (6, 7) and the inward transport of glucose analogues (8) , responses that are independent of new protein synthesis. An unusual feature of the effect of T3 on amino acid accumulation is the fact that 18-adrenergic agonists, which themselves have no effect on amino acid accumulation in this system, promptly synergize the stimulatory effect of T3 (6) . This finding seemed to I Abbreviations used in this paper: 2 point further toward an action mediated at the plasma membrane level. Consequently, we undertook the present studies to ascertain whether a similar interaction between T3 and catecholamines takes place in respect to sugar transport. The data indicate that an analogous, but not identical, synergism does occur.
METHODS
Thymocytes were isolated from weanling female CD rats (25-30 d old, purchased from Charles River Breeding Laboratories, Wilmington, Mass.) by the method previously described by Goldfine et al. (9) with modifications previously employed in this laboratory (8) . In short, rats were sacrificed by cervical dislocation, exsanguinated, and their thymus glands were quickly removed into ice cold Krebs-Ringer-Tris buffer, pH 7.5 (20 mM Tris-HCL, 5 mM Tris-base, 120 mM NaCl, 1 mM CaCl2, 1.5 mM NaH2PO4, 2.5 mM MgCl, and 15 mM Hepes). The glands were washed with the cold buffer and gently teased with forceps. The free cells were filtered through nylon mesh to remove tissue debris and were then centrifuged at 4°C for 5 3,5,3'-Triiodothyronine, the Adrenergic System, and Sugar Transport I cytes that were preincubated with 100,uM epinephrine for 60 min had decreased to 60% but had remained unchanged at -95% in all other vessels, including conitrols.
In view of the foregoing findings, the dose-response relationship for the effect of epinephrine was assessed by using a 20-min preincubation period. Under these conditions, a clear log dose-response relationship was evident (Fig. 2) . The lowest concentration of epinephrine that produced significant stimulation was 1 MuM, whereas the greatest effect was produced by the highest concentration tested (1 mM). Cell viability was unchanged (93-95%) in all specimnens.
At the concentrations of epinephrine routinely employed (.10 utM), cell viability was retained during 60-mnin incubations and the effect on 2-DG uptake was greater than at earlier time periods (Fig. 1) . In view ofthat fact, and because the effect ofT3 is also maximum at 60 min (8) (Fig. 3) . As with epinephrine, a decrease in 2-DG accumulation was produced by 0.1 and 1 mM isoproterenol, which was also associated with a decrease in cell viability to -60 and 20%, respectively.
Effect of phenylephrine. At concentrations ranging between 10 nM and 1 mM, the a-agonist, phenylephrine, had no effect on either 2-DG accumulation or cell viability when preincubated with thymocytes for 60 min (data not shown).
Effect of phentolamine. At concentrations ranging between 10 nM and 1 mM, 60 min preincubation with the a-antagonist, phentolamine, had no effect on 2-DG accumulation or cell viability. Similarly, phentolamine, at concentrations as high as 1 mM, had no significant effect on the stimulatory responses to 1 and 10 4M epinephrine (data not shown).
Effect of propranolol. In individual experiments, propranolol, generally considered a, 8-antagonist, proved to be a weak agonist with respect to 2-DG accumulation, there being no effect at 1 uMM, but stimulatory effects at 10 and 100 ,uM propranolol. These effects were reproduced in experiments shown in (Table I) . Effect of alprenolol. When studied alone, the /8-antagonist alprenolol had no effect on 2-DG accumulation at concentrations ranging between 10 nM and 10 AM. However, significant stimulation of2-DG accumulation (10.5%) was produced by 0.1 mM alprenolol and still greater stimulation (15.9%) by 1 mM alprenolol (Fig. 4) . Thus, like propranolol, alprenolol proved to behave as a weak agonist with respect to 2-DG accumulation. However, unlike propranolol, 1 mM alprenolol had no adverse effect on cell viability.
Effect ofalprenolol with epinephrine. At concentrations that were without effect on 2-DG accumulation when added alone (1-10 AM), alprenolol completely inhibited the stimulatory response to 1 uMM epinephrine and partially but significantly, inhibited the stimulatory response to 10 MM epinephrine (Table II) .
Role of oxidation of epinephrine. To explore the possible involvement of the oxidation of epinephrine in its effect on 2-DG accumulation, studies were performed with the monoamine oxidase inhibitor, pargyline. When added alone in concentrations between 0.1 and 10 AM, pargyline had no effect. Nor did those concentrations of pargyline influence the response to 1 and 10 uMM epinephrine (data not shown).
Spectrophotometric analysis (11) revealed that after as much as 120 min of incubation of thymocytes with 10 ,uM epinephrine, concentrations of adrenochrome were below the limit of detectability (10 nM).
Interactions between adrenergic agents and T3. Because of the fact that, like epinephrine, T3 is capable of enhancing the uptake of 2-DG by rat thymocytes in vitro (8) epinephrine. *-P < 0.05; **-P < 0.01; f indicates significant difference from hormone-free control (P < 0.05).
synergistic interaction of catecholamines and T3. To obtain further evidence to this point, experiments were conducted to determine the effect ofa-adrenergic blockade on the synergistic interaction between T3 and epinephrine. Although, as already described, phentolamine (1 and 10 ,uM) had no effect on 2-DG accumulation when added alone, and did not significantly modify the effects ofT3 or epinephrine added individually, phentolamine at these concentrations completely blocked the synergistic interaction evident when T3 at 0.1 nM and epinephrine (0.1 AuM) were added together (Table III) . Effect of puromycin. Preincubation with puromycin decreased the basal uptake of 3H-2-DG by -20%, but did not significantly affect the percent increase in 3H-2-DG uptake produced by epinephrine, either alone or acting synergistically with T3. In four experiments, epinephrine (10 (Table IV) .
Studies with 3-0-MG. To ascertain whether the effect of epinephrine alone and its synergism with T3 to stimulate the accumulation of 2-DG requires phos- phorylation of the sugar, studies were performed with 3-0-MG, which uses the same membrane transport mechanism as 2-DG does, but, unlike 2-DG, does not undergo phosphorylation. Epinephrine alone at concentrations of 1 and 10 lOM significantly increased the 1-min accumulation of 3-0-MG, but 0.1 ,uM epinephrine did not (Fig. 7) . Stimulatory concentrations of epinephrine were the same as those required in the case of 2-DG accumulation. As previously reported, T3 I Significantly (P < 0.025) different from 10 nM T3 alone.
3,5,3'-Triiodothyronine, the Adrenergic System, and Sugar Transport alone at a concentration of 1 nM significantly stimulated 3-0-MG accumulation, but 0.1 nM T3 was ineffective. When the ineffective concentrations of T3 (0.1 nMI) and epinephrine (0.1 ,uM) were added together, however, a significant stimulation of 3-0-MG uptake was seen.
DISCUSSION
We have previously presented evidence that various in vitro responses to T3 are mediated by extranuclear mechanisms, possibly at the level of the cell membrane (6) (7) (8) . Evidence in support of this view was the ability of T3 in vitro to promptly stimulate, in isolated rat thymnocytes, the accumulation of the amino acid analogues, a-amino isobutyric acid, and cycloleucine, as well as the inward transport of the glucose analogues, 2-DG and 3-0-MG. In the case of cycloleucine accumulation, f8-adrenergic agonists, though themselves without effect, synergistically increased the stimulatory response to T3 (6) . In these studies, we have examined the interaction between T3 and the adrenergic system with respect to sugar transport. it was possible to demonstrate that low concentrations (1 and 10 ,uM), which had no effect when added alone, partly or completely inhibited the stimulatory response to epinephrine. These stimulatory effects of epinephrine and isoproterenol on 2-DG accumulation in rat thymocytes complement a lengthy list of effects of adrenergic agonists on sugar transport and metabolismn in a variety of other tissues that have been reported by previous investigators. There appears to be little or no uniformity in the pattern of response, however, because both stimulatory and inhibitory effects have been described, and because the influence of the adrenergic antagonists on these effects have also been highly variable (12, see review) .
Simlilarly, the foregoing agonistic effects of the classical 83-antagonists on a 13-mediated function, though unusual, are not without precedent. Thus, both epinephrine and propranolol independently stimulate the uptake of 3-0-MG by geese erythrocytes in vitro (13) , and, in the isolated canine heart, the 8-antagonists practolol, and pindolol both act like norepinephrine to enhance glucose uptake (14) . Further, both the chronotropic and inotropic effects of isoproterenol are mimicked by practolol in the isolated rat artium (15) . Similar responses have been seen in other systems (16, 17) .
Itnteraction of T3 alonte with the adrenergic si stenmi. An unusual finding in the present study was the ability of the ,B-adrenergic antagonist, alprenolol, to block the stimulation of2-DG accumulation produced by T3 alone, this occurring in a systemi that should have been devoid of any endogenous catecholamine. The nature of the response to T3 in the presence of propranolol couild not be evaluated, because of propranolol's stronger independent agonistic effect; however, the a-adrenergic antagonist, phentolamiine, had no effect on the stimulatory response to T3.
This in vitro inhibitory effect of alprenolol on the response to T3 alone is reminiscent of that reported by , who demonstrated that thyroxine in vitro increases the erythroid colony forming activity of canine marrow cells and that this stimulation is inhibited by propranolol. Apart from these two responses, we know of no other system in which an effect of thyroid hormone that occurs in the absence of catecholamines is blocked by an adrenergic antagonist.
Interactiotns of T3 anid adreniergic agenits. A major finding of this study, and further evidence of a relationship between the action of T3 and the adrenergic system, is the demonstration of a prompt synergistic interaction between T3 and epinephrine with regard to 2-DG accumnulation. We find this interaction both tunusual and unusually interesting in several respects. Thus, neither the ,3-agonist, isoproterenol, nor the aagonist, phenylephrine, displayed a synergistic interaction with T3 when added separately, though they did so when added together. This effect ofthe combinedl a-and 13-agonists was similar to that of epinephrine, which is known to have both a-and 18-agonistic activity. Furthermore, although phentolamine had no effect on the separate stimulatory effects ofepinephrine and T3, it inhibited the synergistic interaction between the two. From these findings, it appears that al-though the independent effects of T3 and of the catecholamines on 2-DG accumulation by the thymocyte are /8-mediated, their synergistic stimulatory action requires participation of the alpha receptor.
Prompt synergistic interactions between thyroid horinones and catecholamines on defined metabolic responses, have been noted in other systems. For example, T4 has been shown promptly to increase the epinephrine-induced release of a-amylase by rat-parotid gland in vitro (19) . The best studied of such interactions are those in which T3 enhances the in vitro lipolytic response to epinephrine in rat adipose tissue (20) (21) (22) . These interactions differ, however, in several respects from the ones that we describe here. First, in the two foregoing systems, the action of epinephrine alone, like that we describe in thymocytes (6) , is clearly /8-mediated, but the thyroid hormones themselves are said to have no independent stimulatory effect. Second, with respect to these systems, there is no evidence that the participation of an a-component in the synergistic interaction between thyroid hormones and epinephrine is required.
Properties of the response to T3 and adrenergic agents. The stimulatory effect of epinephrine on 2-DG accumulation was evidently not caused by metabolites of epinephrine generated during incubation, rather than by epinephrine itself. Pargyline, a monoamine oxidase inhibitor, did not alter the response to epinephrine, and detectable concentrations of adrenochrome (>10 nM) were not generated during incubations that contained epinephrine in concentrations as high as 10 /M. New protein synthesis was not required for either the effect of epinephrine on 2-DG accumulation or the synergistic stimulatory interaction between epinephrine and T3, because a puromycin concentration that greatly inhibits protein synthesis in this system (8) had no effect on either response.
We have earlier shown that T3 enhances the accumulation of 2-DG in rat thymocytes by increasing the transport of the sugar without affecting its phosphorylation. This conclusion was supported by the finding that T3 also enhanced the accumulation of 3-0-MG, vhich is transported into the cell by the same system as 2-DG, but is not phosphorvlated (8) . In the present experiments ye again used 3-0-MG, this time to determine whether the stimulatory effect of epinephrine and its synergistic interaction with T3 might reflect, not a stimulation of sugar transport, but solely an effect on the phosphorvlation of 2-DG. This proved not to be the case, however, because both the independent effect of epinephrine and its synergistic interaction with T3 in regard to 2-DG accumulation were paralleled by effects on 3-0-MG uptake.
General conclusions. From the data obtained in our present and previous studies of sugar metabolism in rat thymocytes (8) , we are led to conclude that T3 and epinephrine can independently act to stimulate the inward transport of sugars, at least in this cell, and that their independent actions are each mediated at the ,/-adren-
